Pencil Beam Scanning in Patients With Renal Tumors
Recruiting
Early Phase 1
Interventional Study
Renal Tumor
Wilms Tumor
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 0 – 30
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 28 (estimated)
- Sponsor
- Children's Hospital of Philadelphia · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a pilot study to assess acute toxicity in patients receiving flank irradiation using proton therapy for renal tumors.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Less than 30 years of age
* Diagnosis
a. Any patient with Wilms tumor or clear cell sarcoma of the kidney who would require radiation therapy as standard of care including
1. Any patient with favorable histology (FH), stage III disease
2. Any patient with focal or diffu…
Contacts